C.C.D FORMULA 18 DIBUTYLTIN DILAURATE

Main information

  • Trade name:
  • C.C.D FORMULA 18 DIBUTYLTIN DILAURATE
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • C.C.D FORMULA 18 DIBUTYLTIN DILAURATE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • POULTRY BROILERS (MEAT FOR HUMAN CONSUM) | CHICKENS | CHOOKS | MEAT BIRDS
  • Therapeutic area:
  • PARASITICIDES
  • Therapeutic indications:
  • INTERNAL PARASITE | HAEMONCHUS SPP. | OSTERTAGIA SPP. | STOMACH FLUKES | TAPEWORM

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Cancelled
  • Authorization number:
  • 36431
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

29-6-2018

EU/3/18/2028 (BioCryst UK Ltd)

EU/3/18/2028 (BioCryst UK Ltd)

EU/3/18/2028 (Active substance: (R)-1-(3-(aminomethyl) phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride) - Orphan designation - Commission Decision (2018)4173 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/003/18

Europe -DG Health and Food Safety

18-5-2018

EU/3/15/1562 (IQVIA RDS Ireland Limited)

EU/3/15/1562 (IQVIA RDS Ireland Limited)

EU/3/15/1562 (Active substance: A highly purified formulation of Staphylococcus aureus protein A) - Transfer of orphan designation - Commission Decision (2018)3144 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/111/15/T/01

Europe -DG Health and Food Safety